-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Amrize, Raises Price Target to $46

Benzinga·11/16/2026 16:03:44
語音播報
UBS analyst Julian Radlinger maintains Amrize (NYSE:AMRZ) with a Neutral and raises the price target from $42 to $46.